Summary of Purpose
The aim of this study is to evaluate the present status of stroke prevention strategies in patients with non-valvular atrial fibrillation (NVAF). Vitamin K antagonists (VKAs) have been the only available oral anticoagulant therapy for decades. Recently novel oral anticoagulants have emerged as an alternative for VKAs. This study is planned to evaluate the epidemiological characteristics, thromboembolic and...Read More →
The following dates are available for this trial. Trial information last updated on 22 September 2015.
|1 Feb 2015||18 Jan 2015||1 Apr 2015||1 May 2015||1 Sep 2015||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Cross-Sectional
- Sampling: Non-Probability Sample
- Murat Biteker, Assoc. Prof.
- Ozcan Basaran, M.D.